[1] Rask-Andersen M, Ivansson E, Höglund J, et al. Adiposity and sex-specific cancer risk. Cancer Cell, 2023; 41, 1186-97. e4.
[2] Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer—viewpoint of the IARC working group. N Engl J Med, 2016; 375, 794−8. doi:  10.1056/NEJMsr1606602
[3] Pearson-Stuttard J, Zhou B, Kontis V, et al. Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol, 2018; 6, E6−15.
[4] NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet, 2017; 390, 2627−42. doi:  10.1016/S0140-6736(17)32129-3
[5] Pan XF, Wang LM, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol, 2021; 9, 373−92. doi:  10.1016/S2213-8587(21)00045-0
[6] Liu C, Yuan YC, Guo MN, et al. Rising incidence of obesity-related cancers among younger adults in China: a population-based analysis (2007-2021). Med, 2024; 5, 1402-12. e2.
[7] Xiao TL, Yuan SQ, Gao JY, et al. Predictive ability of hypertriglyceridemic waist, hypertriglyceridemic waist-to-height ratio, and waist-to-hip ratio for cardiometabolic risk factors clustering screening among Chinese children and adolescents. Biomed Environ Sci, 2024; 37, 233−41.
[8] The State Council the People's Republic of China. China launches 3-year campaign on public weight management. https://english.www.gov.cn/news/202406/26/content_WS667c12e4c6d0868f4e8e8975.html. [2025-11-05]
[9] Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut, 2015; 64, 1637−49. doi:  10.1136/gutjnl-2014-309086
[10] Atkin W, Wooldrage K, Parkin DM, et al. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial. Lancet, 2017; 389, 1299−311. doi:  10.1016/S0140-6736(17)30396-3
[11] D’Andrea E, Ahnen DJ, Sussman DA, et al. Quantifying the impact of adherence to screening strategies on colorectal cancer incidence and mortality. Cancer Med, 2020; 9, 824−36. doi:  10.1002/cam4.2735
[12] Chen HD, Li N, Ren JS, et al. Participation and yield of a population-based colorectal cancer screening programme in China. Gut, 2019; 68, 1450−7. doi:  10.1136/gutjnl-2018-317124
[13] Senore C, Inadomi J, Segnan N, et al. Optimising colorectal cancer screening acceptance: a review. Gut, 2015; 64, 1158−77. doi:  10.1136/gutjnl-2014-308081
[14] Dong XS, Du LB, Luo ZL, et al. Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: a population-based cohort study. PLoS Med, 2024; 21, e1004340. doi:  10.1371/journal.pmed.1004340
[15] National Clinical Practice Guideline on Obesity Management Editorial Committee. National clinical practice guideline on obesity management (2024 edition). Chin Circ J, 2025; 40, 6−30. (In Chinese)
[16] World Health Organization. Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. [2025-11-05]
[17] Guo F, Chen C, Schöttker B, et al. Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: prospective cohort study. Int J Cancer, 2020; 146, 2423−32. doi:  10.1002/ijc.32566
[18] Blanks RG, Benson VS, Alison R, et al. Nationwide bowel cancer screening programme in England: cohort study of lifestyle factors affecting participation and outcomes in women. Br J Cancer, 2015; 112, 1562−7. doi:  10.1038/bjc.2015.69
[19] Kendall KA, Lee E, Zuckerman IH, et al. Obesity status and colorectal cancer screening in the United States. J Obes, 2013; 2013, 920270.
[20] Gangcuangco LMA, Rivas T, Basnet A, et al. Factors associated with colorectal cancer screening adherence and the impact of COVID-19 on screening patterns in Connecticut, USA. Intern Emerg Med, 2022; 17, 2229−35. doi:  10.1007/s11739-022-03053-2
[21] Li JB, Ke KJ, Zhang WL, et al. Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms. Cancer Med, 2022; 11, 4321−31. doi:  10.1002/cam4.4730
[22] Upton A, Spirou D, Craig M, et al. Health literacy and obesity: a systematic scoping review. Obes Rev, 2025; 26, e13904. doi:  10.1111/obr.13904
[23] Phelan SM, Burgess DJ, Yeazel MW, et al. Impact of weight bias and stigma on quality of care and outcomes for patients with obesity. Obes Rev, 2015; 16, 319−26. doi:  10.1111/obr.12266
[24] Bhaskaran K, Douglas I, Forbes H, et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet, 2014; 384, 755−65. doi:  10.1016/S0140-6736(14)60892-8